Page last updated: 2024-08-23

flubendazole and fluorouracil

flubendazole has been researched along with fluorouracil in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cen, S; Chen, W; Li, C; Luo, J; Mao, X; Shu, F; Tan, X; Wu, K; Yang, T; Yang, Y; Zhou, X; Zou, L	1

Other Studies

1 other study(ies) available for flubendazole and fluorouracil

Article	Year
Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer. Pharmacological research, 2021, Volume: 164 Topics: Amino Acid Transport System y+; Animals; Anthelmintics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line; Cell Survival; Ferroptosis; Fluorouracil; Humans; Male; Mebendazole; Mice, Nude; Phospholipid Hydroperoxide Glutathione Peroxidase; Prostatic Neoplasms, Castration-Resistant; Tumor Suppressor Protein p53	2021

Article

Year

Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer.

Pharmacological research, 2021, Volume: 164

Topics: Amino Acid Transport System y+; Animals; Anthelmintics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line; Cell Survival; Ferroptosis; Fluorouracil; Humans; Male; Mebendazole; Mice, Nude; Phospholipid Hydroperoxide Glutathione Peroxidase; Prostatic Neoplasms, Castration-Resistant; Tumor Suppressor Protein p53

2021